Alnylam Pharmaceuticals
ALNY
#443
Rank
NZ$91.82 B
Marketcap
NZ$695.08
Share price
1.06%
Change (1 day)
63.75%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company